153 related articles for article (PubMed ID: 37879898)
21. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
Illa I
J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
[TBL] [Abstract][Full Text] [Related]
22. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
[TBL] [Abstract][Full Text] [Related]
24. [CIDP Refractory to Three Types of Mainstay Treatments: Differential Diagnosis and Treatment Strategies].
Iijima M
Brain Nerve; 2022 May; 74(5):517-524. PubMed ID: 35589641
[TBL] [Abstract][Full Text] [Related]
25. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
[TBL] [Abstract][Full Text] [Related]
26. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
[TBL] [Abstract][Full Text] [Related]
27. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.
Wang Z; Zhou X; Zhao N; Xie C; Zhu D; Guan Y
Neurol Sci; 2021 Jun; 42(6):2223-2233. PubMed ID: 33782779
[TBL] [Abstract][Full Text] [Related]
28. CIDP/autoimmune nodopathies with nephropathy: a case series study.
Tang Y; Liu J; Gao F; Hao H; Jia Z; Zhang W; Shi X; Liang W; Yu M; Lv H; Tan Y; Li Z; Wang Y; Yuan Y; Meng L; Wang Z
Ann Clin Transl Neurol; 2023 May; 10(5):706-718. PubMed ID: 36932648
[TBL] [Abstract][Full Text] [Related]
29. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Martín-Aguilar L; Querol L
Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
[TBL] [Abstract][Full Text] [Related]
31. [The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies].
Ogata H
Rinsho Shinkeigaku; 2023 Nov; 63(11):715-724. PubMed ID: 37880115
[TBL] [Abstract][Full Text] [Related]
32. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
33. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins.
Yang MG; Xu L; Ji S; Gao H; Zhang Q; Bu B
Neuropsychiatr Dis Treat; 2022; 18():1207-1217. PubMed ID: 35734550
[TBL] [Abstract][Full Text] [Related]
35. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
[TBL] [Abstract][Full Text] [Related]
36. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
37. Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatment.
Godil J; Barrett MJ; Ensrud E; Chahin N; Karam C
J Neurol Sci; 2020 Nov; 418():117098. PubMed ID: 32841917
[TBL] [Abstract][Full Text] [Related]
38. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
Bai Y; Li W; Yan C; Hou Y; Wang Q
Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
[TBL] [Abstract][Full Text] [Related]
39. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
[TBL] [Abstract][Full Text] [Related]
40. Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review.
Zhao M; Chen G; Li S; Li X; Chen H; Lou Z; Ouyang H; Zhan Y; Du C; Zhao Y
Front Immunol; 2024; 15():1368487. PubMed ID: 38846936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]